50 Participants NeededMy employer runs this trial

Transcranial Magnetic Stimulation for PTSD

Recruiting at 1 trial location
No Placebo GroupAll trial participants will receive the active study treatment (no placebo)

What You Need to Know Before You Apply

What is the purpose of this trial?

This trial aims to determine if Transcranial Magnetic Stimulation (TMS), a non-invasive brain treatment, can help prevent chronic PTSD and depression when administered shortly after trauma. Researchers seek to discover if TMS can alter the brain's response to threats, potentially reducing the risk of developing long-term PTSD. Participants will undergo sessions of either real or sham (placebo) TMS to compare the effects. The trial seeks individuals who have experienced a traumatic event in the last two weeks and are experiencing high PTSD symptoms related to that event. As an unphased trial, this study offers a unique opportunity to contribute to groundbreaking research on PTSD prevention.

Will I have to stop taking my current medications?

You can continue taking your current medications, like antidepressants or antipsychotics, as long as the dosage has been stable for at least 6 weeks and doesn't change during the study.

What prior data suggests that Transcranial Magnetic Stimulation (TMS) is safe for PTSD?

Research has shown that Transcranial Magnetic Stimulation (TMS) is generally safe for treating PTSD. Studies have found that patients tolerate TMS well, with no serious side effects reported. Some individuals might experience mild side effects, such as headaches, but these are usually temporary and not serious.

In several studies, TMS effectively reduced PTSD symptoms for many patients. For instance, one study found that 77.1% of patients showed improvement, and 61.5% experienced a significant reduction in symptoms. While TMS might not immediately change PTSD severity, it has shown potential to help over time.

Overall, TMS is a safe option for those with PTSD and is generally well-tolerated.12345

Why are researchers excited about this trial?

Transcranial Magnetic Stimulation (TMS) is unique because it offers a non-invasive approach to treating PTSD, unlike traditional options like psychotherapy and medications such as SSRIs. TMS uses magnetic fields to stimulate nerve cells in the brain, potentially offering a new mechanism of action by directly targeting areas associated with mood regulation and stress response. Researchers are excited about TMS because it could provide faster relief with fewer side effects, making it a promising alternative for those who haven’t found success with conventional treatments.

What evidence suggests that Transcranial Magnetic Stimulation is effective for PTSD?

Research has shown that Transcranial Magnetic Stimulation (TMS) can help reduce PTSD symptoms. In one study, 85% of patients who received TMS experienced a significant reduction in symptoms, compared to 59% in a group that received a sham treatment. Another study found that 77.1% of patients responded well to TMS, and 61.5% saw their symptoms become much less severe. Meta-analyses also support TMS as an effective treatment for PTSD over time. In this trial, participants will undergo both active TMS and sham (placebo) TMS sessions to evaluate TMS's effectiveness in reducing PTSD symptoms. Overall, evidence suggests TMS can help many people by reducing the intensity of PTSD symptoms.25678

Who Is on the Research Team?

Sv

Sanne van Rooij, PhD

Principal Investigator

Emory University

Are You a Good Fit for This Trial?

This trial is for adults aged 18-65 who have experienced a traumatic event in the past two weeks and are showing high early symptoms of PTSD from that trauma. Participants must be able to consent, have stable medication doses if on psychiatric meds, and not have certain medical or mental health conditions.

Inclusion Criteria

I have been on the same dose of my psychiatric medication for at least 6 weeks.
I am between 18 and 65 years old.
Trauma exposed within the last 2 weeks
See 3 more

Exclusion Criteria

Having active suicidal intent or plan, or in the clinician's opinion, is likely to attempt suicide within the next six months
Lifetime diagnosis of psychotic disorder or bipolar disorder per psychiatric screener
History of cranial surgery, metallic particles in the eye or head (exclusive of mouth), implanted cardiac pacemaker or any intracardiac lines, implanted neurostimulators, intra-cranial implants (e.g., aneurysm clips, shunts, stimulators, cochlear implants, or electrodes), or implanted medical pumps
See 2 more

Timeline for a Trial Participant

Screening

Participants are screened for eligibility to participate in the trial

2-4 weeks

Treatment

Participants receive Transcranial Magnetic Stimulation (TMS) sessions, including both active and sham components, to test its effect on brain activity linked to PTSD.

2 days
Multiple sessions over 2 days

Follow-up

Participants are monitored for changes in amygdala threat reactivity and overall brain activity post-TMS intervention.

2 days
Day 1 and Day 2 post-TMS intervention

Long-term Follow-up

Participants are monitored for long-term effects of TMS on PTSD symptoms and brain activity.

3 months

What Are the Treatments Tested in This Trial?

Interventions

  • Transcranial Magnetic Stimulation (TMS)

Trial Overview

The study is testing whether transcranial magnetic stimulation (TMS), a non-invasive brain stimulation technique, given soon after trauma can help prevent long-term PTSD. Some participants will receive real TMS while others get a sham (inactive) version for comparison.

How Is the Trial Designed?

2

Treatment groups

Experimental Treatment

Placebo Group

Group I: Transcranial Magnetic Stimulation (TMS)Experimental Treatment1 Intervention
Group II: Control ApplicationPlacebo Group1 Intervention

Find a Clinic Near You

Who Is Running the Clinical Trial?

Emory University

Lead Sponsor

Trials
1,735
Recruited
2,605,000+

National Institute of Mental Health (NIMH)

Collaborator

Trials
3,007
Recruited
2,852,000+

Citations

1.

pubmed.ncbi.nlm.nih.gov

pubmed.ncbi.nlm.nih.gov/33940319/

Transcranial magnetic stimulation as a treatment for ...

Transcranial magnetic stimulation (TMS) has shown positive outcomes for people with PTSD, using different treatment protocols. This meta- ...

Effectiveness of transcranial magnetic stimulation for ...

Currently, meta-analyses of TMS for PTSD outnumber novel RCT publications and indicate that TMS is generally effective at PTSD symptom reduction over time, with ...

Residential Therapy With Navigated Transcranial Magnetic ...

Clinically significant reductions in PTSD symptoms were achieved by 85% of active TMS vs 59% of sham recipients at 1-month follow-up. Meaning ...

Transcranial Magnetic Stimulation for Post-traumatic Stress ...

Studies have been done to assess the overall efficacy of TMS. However, results have been conflicting, and sample sizes were small. More research should be done ...

Pragmatic accelerated transcranial magnetic stimulation for ...

A total of 74 patients (77.1 %) achieved a clinical response with accelerated TMS, and PTSD remission occurred in 59 (61.5 %) (Fig. 1A).

6.

pubmed.ncbi.nlm.nih.gov

pubmed.ncbi.nlm.nih.gov/39092744/

Repetitive transcranial magnetic stimulation for post- ...

Based on moderate-certainty evidence, our review suggests that active rTMS probably makes little to no difference to PTSD severity ...

Accelerated Transcranial Magnetic Stimulation for Post- ...

The study checks if this approach is practical, safe (tracking side effects like headaches), and shows early signs of reducing PTSD symptoms ( ...

Efficacy of transcranial magnetic stimulation in the ...

Five studies reported pre–post data on PTSD symptom severity. The pooled within-group analysis demonstrated a significant reduction in PTSD symptoms following ...